One Put, One Call Option To Know About For Merck & Co.
Selling a put does not give an investor access to MRK's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. So unless Merck & Co., Inc sees its shares fall 4% and the contract is exercised (resulting in a cost basis of $51.45 per share before broker commissions, subtracting the $1.05 from $52.50), the only upside to the put seller is from collecting that premium for the 10.7% annualized rate of return.
Interestingly, that annualized 10.7% figure actually exceeds the 3.2% annualized dividend paid by Merck & Co., Inc by 7.5%, based on the current share price of $54.69. And yet, if an investor was to buy the stock at the going market price in order to collect the dividend, there is greater downside because the stock would have to lose 4% to reach the $52.50 strike price.